Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Kandice Kottke-Marchant, MD, PhD

216.444.2484

Kandice Kottke-Marchant, MD, PhD

Appointed: 1990

Kandice Kottke-Marchant, MD, PhD
Department: Pathology and Laboratory Medicine Institute
Institute Chair
Location: Cleveland Clinic Main Campus
Mail Code L21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2484
WorkFax:216.445.9535
Kandice Kottke-Marchant, MD, PhD
Department: Clinical Pathology
Section Head
Location: Cleveland Clinic Main Campus
Mail Code L21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2484
WorkFax:216.445.9535
Kandice Kottke-Marchant, MD, PhD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code L21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2484
WorkFax:216.445.9535
Kandice Kottke-Marchant, MD, PhD
Department: Molecular Cardiology
Location: Cleveland Clinic Main Campus
Mail Code L21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2484
WorkFax:216.445.9535
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Kandice Kottke-Marchant, MD, PhD, is Chair of the Pathology and Laboratory Medicine Institute at Cleveland Clinic.

Dr. Kottke-Marchant earned a BS degree in biomedical engineering and biochemistry from Northwestern University in Evanston, Ill., in 1979. She earned her MS and PhD degrees in macromolecular science in 1983 and 1985, respectively, from Case Western Reserve University in Cleveland, Ohio. She received an MD from CWRU in 1986.

Professional Highlights

  • President, International Society of Laboratory Hematology, 2008-Present
  • Executive Secretary, International Society of Laboratory Hematology, 2002-2007
  • Hematology Test Development and Advisory Committee, American Board of Pathology, 2007-Present
  • Executive Board, NASCOLA (North American Specialized Coagulation Laboratory Association), 2007-Present
  • Hematology and Pathology Devices Panel, Medical Devices Advisory Committee, U.S. Food and Drug Administration, 2007-Present

Education & Fellowships

Residency - Cleveland Clinic
Anatomic & Clinical Pathology
Cleveland, OH USA
1990
Medical School - Case Western Reserve University School of Medicine
Cleveland, OH USA
1986
Doctorate - Case Western Reserve University
Macromolecular Science
Cleveland, OH USA
1985
Graduate - Case Western Reserve University
Macromolecular Science
Cleveland, OH USA
1983
Undergraduate - Northwestern University
Biomedical Engineering
Evanston, IL USA
1979

Certifications

  • Anatomic & Clinical Pathology- Hematology
  • Anatomic & Clinical Pathology

Specialty Interests

thrombosis, hemostasis and vascular disease, hypercoagulable states, bleeding disorders, endothelial cell function, atherosclerosis

Awards & Honors

  • Recipient, Berend Houwen Memorial Lecture, International Society of Laboratory Hematology, Miami, Fla., May 8-11, 2007
  • Fellow, American Institute for Medical and Biological Engineering, Inducted 2002
  • Teacher of the Year, Pathology Department, Division of Medical Education and House Staff Association, 2001
  • Recipient, John Beach Hazard Distinguished Teacher Award, Cleveland Clinic, 2000
  • Recipient, First Annual Young Investigator Award, Society for Cardiovascular Pathology, 1989
  • Chief Resident, Department of Pathology, Cleveland Clinic, Cleveland, Ohio, 1988-1989
  • Alpha Omega Alpha Medical Honor Society, Case Western Reserve University, 1986
  • Tau Beta Pi, Engineering Honorary Society, Northwestern University, 1978

Memberships

  • International Society of Laboratory Hematology
  • American Society of Hematology
  • College of American Pathologists
  • International Society for Thrombosis and Haemostasis
  • American Institute for Medical and Biological Engineering

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/5/2014, Dr. Kottke-Marchant has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Kottke-Marchant serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

  • Nanomimetics, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English